EP3013366
COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
27.6.2014:
25.8.2021:
14739078.5
:
26.6.2034
:
COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR
27.6.2014
25.8.2021
:
CSL Behring GmbH:
Emil-von-Behring-Strasse 76, 35041 Marburg, DE
:
NOLTE, Marc:
35041 Marburg, DE
:
PRAGST, Ingo:
34549 Edertal, DE
:
201361840662 P:
28.6.2013:
US
:
13176605:
16.7.2013:
EP
:
EP2014063691:
27.6.2014
:
A61K 38/57, A61K 39/395, A61K 31/4365, A61K 31/519, A61K 31/60, A61K 31/616, A61K 31/727, A61K 45/06, C07K 16/36, A61P 3/00, A61P 7/02, A61P 7/10, A61P 9/00, A61P 9/10, A61P 11/00, A61P 21/00, A61P 25/00, A61P 29/00, A61P 43/00